Fidelity European Trust: Over 30% NAV and share price 3 year growth

Fidelity

Fidelity European Trust plc (LON:FEV) has published its fact sheet for the period to 31 December 2022.

Portfolio Manager Commentary 

Continental European equities edged lower in December after the European Central Bank (ECB) raised interest rates by 0.5% at its December meeting, bringing the deposit facility rate to 2%. The ECB said that significant rate hikes are expected at a steady pace to ensure that inflation returns to its 2% target. The central bank announced that it would begin to shrink its asset purchase programme portfolio in March by stopping the reinvestment of EUR 15 billion per month of maturing bonds. Solid US economic data led to renewed fears that the ECB may remain hawkish for longer, while a downward revision to the UK’s GDP added to the bearish sentiment. Against this backdrop, all sectors ended the month in negative territory, with IT stocks leading the laggards. From a style perspective, value stocks outperformed their growth counterparts and small-cap names outperformed their large and mid-cap counterparts.

During the month, the Trust’s NAV slightly underperformed the index. The overweight stance in technology and stock selection in financials weighed on returns, although security selection contributed to performance in the health care sector. At a stock level, private equity company Partners Group was a notable detractor amid concerns over high management fees and pressure on assets under management.

On a rolling 12-month basis, the Trust recorded NAV and share price returns of -3.6% and -3.8% respectively, compared to -7.0% for the index.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

European equities hold ground ahead of policy shifts

European equities edge up as investors navigate a week of policy signals and key data with deliberate caution.

European defence stocks climb on German procurement momentum

Germany’s military procurement plans have kicked defence stocks into motion, giving investors a clearer signal on where the capital is headed.

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

Search

Search